01 / Vendor Profile
OLOGY BIOSERVICES, INC. Federal Contracts and Awards
UEI GC2RFAZK8G64 · CAGE 3GQS9
Federal contract activity attributed to this vendor identity across FY 2019–FY 2025. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, FPDS records attribute $249.13M in net contract obligations to OLOGY BIOSERVICES, INC. across 123 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
OLOGY BIOSERVICES, INC. contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations-$20.09M
FY 2025ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2019 | $28.26M | 16 | 3 | — |
| FY 2020 | $66.34M | 19 | 3 | +134.8% |
| FY 2021 | $44.17M | 11 | 2 | −33.4% |
| FY 2022 | $49.90M | 15 | 2 | +13.0% |
| FY 2023 | $47.38M | 29 | 3 | −5.0% |
| FY 2024 | $33.18M | 19 | 2 | −30.0% |
| FY 2025 | -$20.09M | 14 | 2 | −160.5% |
04 / Federal Customers
Which federal agencies buy from OLOGY BIOSERVICES, INC.?
Ranked by net obligations during FY 2019–FY 2025.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 2100 | $233.05M | 92 | 93.5% | |
| 7529 | $16.09M | 25 | 6.5% | |
| 7505 | -$20 | 6 | 0.0% |
05 / Contracting Offices
Which contracting offices buy from OLOGY BIOSERVICES, INC.?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| W911QY | DEPT OF THE ARMY | $129.93M | 32 | 52.2% | |
| W911SR | DEPT OF THE ARMY | $103.11M | 60 | 41.4% | |
| 75N930 | NATIONAL INSTITUTES OF HEALTH | $16.09M | 25 | 6.5% | |
| 75A501 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | -$20 | 6 | 0.0% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $130.56M | 39 | 1 | 52.4% |
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $101.77M | 48 | 1 | 40.8% |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $15.84M | 22 | 2 | 6.4% |
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | $969.1K | 8 | 1 | 0.4% |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | -$20 | 6 | 1 | 0.0% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| AN42 | HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH | $101.77M | 48 | 1 | 40.8% |
| 6505 | DRUGS AND BIOLOGICALS | $92.02M | 9 | 2 | 36.9% |
| AE37 | R&D- ECONOMIC GROWTH: MANUFACTURING TECHNOLOGY (COMMERCIALIZED) | $38.53M | 36 | 1 | 15.5% |
| AN12 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $16.17M | 24 | 1 | 6.5% |
| AN93 | R&D- MEDICAL: OTHER (ADVANCED DEVELOPMENT) | $722.2K | 5 | 1 | 0.3% |
| AN13 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | -$81.6K | 1 | 1 | 0.0% |
08 / Competition Pattern
How was OLOGY BIOSERVICES, INC.’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for OLOGY BIOSERVICES, INC.?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| W911SR22F0014 | Sep 23, 2025 | -$3.08M | DEPT OF THE ARMY W6QK ACC-APG | 541715 | AN42 |
10 / Interpreting the Profile
How should you evaluate OLOGY BIOSERVICES, INC. as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.